In addition, CD31 immunohistochemistry was identified to be valuable in the differential diagnosis; however, a variety of markers are required for the diagnosis of angiosarcoma, such as CD34, FVIII, vimentin and pan-CK. This evidence concerns the gene PECAM1 and angiosarcoma.